Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 1 (January)

1. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.
   Gastroenterology, 134(1): 95-101. [Abstract] [Full-text]
2. Phosphorylation of SNAP-25 at Ser187 mediates enhancement of exocytosis by a phorbol ester in INS-1 cells.
   J Neurosci, 28(1): 21-30. [Abstract] [Full-text]
3. Gastroenteropancreatic neuroendocrine tumours.
   Lancet Oncol, 9(1): 61-72. [Abstract] [Full-text]
4. Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.
   Lancet Oncol, 9(1): 39-44. [Abstract] [Full-text]
5. Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study.
   Cancer Invest, 26(1): 47-52. [Abstract] [Full-text]
6. Genetic susceptibility in pancreatic ductal adenocarcinoma.
   Br J Surg, 95(1): 22-32. [Abstract] [Full-text]
7. Pancreatic insufficiency after different resections for benign tumours.
   Br J Surg, 95(1): 85-91. [Abstract] [Full-text]
8. Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.
   Cancer Chemother Pharmacol, 61(4): 661-8. [Abstract] [Full-text]
9. A late phase II study of S-1 for metastatic pancreatic cancer.
   Cancer Chemother Pharmacol, 61(4): 615-21. [Abstract] [Full-text]
10. Adjuvant therapy for pancreatic cancer: a review.
    Cancer, 112(2): 243-9. [Abstract] [Full-text]
11. Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
    Bioorg Med Chem, 16(1): 181-9. [Abstract] [Full-text]
12. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
    Am J Surg, 195(2): 221-8. [Abstract] [Full-text]
13. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
    Eur J Surg Oncol, 34(2): 191-5. [Abstract] [Full-text]
14. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Hum Pathol, 39(2): 251-8. [Abstract] [Full-text]
15. Cystic pancreatic neoplasm in pregnancy: a case report and review of the literature.
    Arch Surg, 143(1): 84-6. [Abstract] [Full-text]
16. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
    Arch Surg, 143(1): 75-83; discussion 83. [Abstract] [Full-text]
17. CT of serous cystadenoma of the pancreas and mimicking masses.
    AJR Am J Roentgenol, 190(2): 406-12. [Abstract] [Full-text]
18. Dual-phase CT of autoimmune pancreatitis: a multireader study.
    AJR Am J Roentgenol, 190(2): 280-6. [Abstract] [Full-text]
19. Differences in antitumor effects of various statins on human pancreatic cancer.
    Int J Cancer, 122(6): 1214-21. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.